NCT01961375View on ClinicalTrials.gov

MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS Study

CompletedOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

October 30, 2015

Primary Completion Date

November 28, 2018

Study Completion Date

September 21, 2023

Conditions

Contraception

Interventions

DRUG

Levonorgestrel- Intra Uterine System (BAY 86-5028_Mirena)

Levonorgestrel 52 mg intrauterine system with release rate of upto 20 mcg/day, Intrauterine insertion

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY